<DOC>
	<DOCNO>NCT02148939</DOCNO>
	<brief_summary>Many patient suffer acute chronic pain . The incidence chronic pain correlate increase age . Most patient rely analgesic medication control pain . Dipyrone extensively use drug Western Eastern Europe well Central South America , largely due favorable analgesic antipyretic effect conjunction low incidence gastrointestinal complication compare non-steroidal anti-inflammatory drug ( NSAIDs ) . Aspirin backbone antiplatelet therapy patient ischemic stroke . However , know substantial inter-individual response variability antiplatelet medication . Furthermore , patient impaired response aspirin significant high risk recurrent cerebrovascular event . The investigator recently show co-medication aspirin dipyrone patient coronary artery disease lead insufficient antiplatelet effect aspirin . The incidence chronic pain high patient ischemic stroke . Therefore , study investigator aim examine , co-medication aspirin dipyrone interaction also occur patient ischemic stroke .</brief_summary>
	<brief_title>Antiplatelet Effects Stroke-Patients</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Dipyrone</mesh_term>
	<criteria>Age â‰¥ 18 year Patients ischemic stroke ASSmedication ( 80320 mg/day ) with/without analgesic comedication Reanimation cardiogenic shock</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>ischemic stroke</keyword>
	<keyword>Antiplatelet Effects</keyword>
	<keyword>aspirin</keyword>
	<keyword>metamizole</keyword>
	<keyword>dipyrone</keyword>
</DOC>